The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 362.80
Bid: 357.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 5.00 (1.401%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 362.80
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Meeting

6 Feb 2024 11:55

RNS Number : 2050C
QinetiQ Group plc
06 February 2024
 

QINETIQ GROUP PLC

6 February 2024

QINETIQ GROUP PLC

Results of General Meeting held on 6 February 2024

Poll Results of General Meeting

QinetiQ Group plc (QinetiQ) announces that the resolution proposed as an ordinary resolution at its General Meeting (GM) held on 6 February 2024 was duly passed without amendment by the requisite majority of shareholders and the results of the poll are as follows:

VOTES FOR

%

VOTES AGAINST

%

TOTAL VOTES VALIDLY CAST

% OF SHARE CAPITAL WITH VOTING RIGHTS

VOTES WITHHELD

1

To authorise the Company to make market purchases of its ordinary shares pursuant to section 701 of the Companies Act 2006

485,836,928

99.51

2,371,173

0.49

488,208,101

84.35

688,113

Notes:

1. The percentages above are rounded to two decimal places.

2. Votes "for" include discretionary votes.

3. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "for" and "against" a resolution.

4. The number of ordinary shares in issue at 6.30pm on 2 February 2024 was 578,757,121 of which none are held in treasury. Therefore the number of ordinary shares with voting rights at 6.30pm on 2 February 2024 was 578,757,121.

Results of the poll can also be viewed on QinetiQ's website: https://www.qinetiq.com/en/investors/shareholder-services/agm

Following the resolution being duly passed, the share buyback programme as previously announced on 16 January 2024 (the Programme) will commence on 7 February 2024.

The first tranche of up to £50 million will be carried out through an irrevocable non-discretionary agreement with Barclays Capital Securities Limited (Barclays) on the basis set out in the announcement of the Programme on 16 January 2024. Barclays may undertake transactions in QinetiQ shares (which may include sales and hedging activities, in addition to purchases which may take place on any available trading venue or an over the counter basis) during the Programme in order to manage their market exposure under the Programme. Disclosure of such transactions will not be made by Barclays as a result of or part of the Programme, but Barclays will continue to make any disclosures they are otherwise legally required to make.

In accordance with Listing Rule 9.6.2, a copy of the resolution will be submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information please contact:

John Haworth, Group Director Investor Relations: +44 (0) 7920 545841

Lindsay Walls, Group Director Communications: +44 (0) 7793 427582

James Field, Company Secretary: +44 (0) 7841 662957

QinetiQ Group plc LEI: 213800S8OBDOZMCMUW34

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMFLFELFFIRIIS
Date   Source Headline
10th Feb 202111:32 amRNSDirector/PDMR Shareholding
8th Feb 20219:57 amRNSDirector/PDMR Shareholding
13th Jan 20217:00 amRNSThird Quarter Trading Update
12th Jan 20219:49 amRNSDirector/PDMR Shareholding
4th Jan 20217:00 amRNSQinetiQ wins £127m Typhoon contract through EDP
21st Dec 20204:44 pmRNSHolding(s) in Company
10th Dec 202010:28 amRNSDirector/PDMR Shareholding
3rd Dec 20201:00 pmRNSSale of OptaSense to Luna
24th Nov 20201:31 pmRNSDirector/PDMR Shareholding
20th Nov 202012:37 pmRNSDirector/PDMR Shareholding
20th Nov 202011:43 amRNSHolding(s) in Company
17th Nov 202011:16 amRNSDirector/PDMR Shareholding
12th Nov 20207:00 amRNSInterim Results
10th Nov 202010:47 amRNSDirector/PDMR Shareholding
12th Oct 202010:09 amRNSDirector/PDMR Shareholding
5th Oct 20209:10 amRNSHolding(s) in Company
30th Sep 20207:00 amRNSPre-close Trading update
21st Sep 20203:57 pmRNSDirectorate Change
10th Sep 202010:29 amRNSDirector/PDMR Shareholding
20th Aug 20202:14 pmRNSHolding(s) in Company
13th Aug 20204:47 pmRNSDirector/PDMR Shareholding
11th Aug 202011:56 amRNSDirector/PDMR Shareholding
10th Aug 202011:28 amRNSTotal Voting Rights
4th Aug 20203:59 pmRNSBlock Listing Application
31st Jul 202012:50 pmRNSTransfer of Treasury Shares & Total Voting Rights
14th Jul 20202:00 pmRNSResult of Annual General Meeting
14th Jul 20207:00 amRNSQ1 Trading Update and Acquisition of Naimuri
13th Jul 20203:51 pmRNSQinetiQ enters next phase of growth in the US
10th Jul 202011:52 amRNSDirector/PDMR Shareholding
1st Jul 202010:50 amRNSDirector/PDMR Shareholding
1st Jul 202010:49 amRNSTotal Voting Rights
1st Jul 202010:46 amRNSDirector/PDMR Shareholding
25th Jun 20207:00 amRNSDisposal of Boldon James to HelpSystems
23rd Jun 202011:46 amRNSDirector/PDMR Shareholding
12th Jun 202010:48 amRNSAnnual Financial Report
10th Jun 202012:31 pmRNSDirector/PDMR Shareholding
21st May 20207:00 amRNSPreliminary Results
19th May 20204:05 pmRNSDirectorate Change
12th May 202011:22 amRNSDirector/PDMR Shareholding
1st May 202011:16 amRNSBlock listing Interim Review
30th Apr 20207:00 amRNSAppointment of Broker
29th Apr 20204:17 pmRNSHolding(s) in Company
15th Apr 202010:35 amRNSDirector/PDMR Shareholding
1st Apr 20209:33 amRNSHolding(s) in Company
1st Apr 20207:00 amRNSTrading and COVID-19 update
20th Mar 202010:21 amRNSDirector/PDMR Shareholding
18th Mar 20202:13 pmRNSHolding(s) in Company
10th Mar 202011:13 amRNSDirector/PDMR Shareholding
11th Feb 202010:53 amRNSDirector/PDMR Shareholding
10th Feb 202012:14 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.